Storia in 4 fonti

23andMe Sold To Biotechnology Company For $256 Million

The acquisition comes two months after the genetic testing company filed for Chapter 11 bankruptcy protection.

Raccontata da

Confronto fonti

4 prospettive sulla stessa storia

AI · summaries

huffpost.comStai leggendo1 anni fa

23andMe Sold To Biotechnology Company For $256 Million

The acquisition comes two months after the genetic testing company filed for Chapter 11 bankruptcy protection.

originale

upi.com1 anni fa

Regeneron Pharmaceuticals to pay $256 million for 23andMe in bankruptcy sale - UPI.com

Regeneron Pharmaceuticals announced Monday it plans to purchase human genetics and biotechnology firm 23andMe from bankruptcy protection in a $256 million deal.

Leggi questa versione → originale

Timeline cronologica

lunedì 19 maggio 2025·finance.yahoo.com
AMD to sell ZT Systems' manufacturing business to Sanmina in $3 billion deal
Chipmaker AMD agreed on Monday to sell the data center infrastructure manufacturing business of recently acquired ZT Systems to Sanmina in a $3 billion deal, making the contract…
lunedì 19 maggio 2025·wsj.com
Regeneron to Buy 23andMe Out of Bankruptcy for $256 Million
The move raises privacy concerns as the drugmaker takes control of the genetic data of millions of clients of the once-sizzling DNA-testing startup.

23andMe Sold To Biotechnology Company For $256 Million

Regeneron Pharmaceuticals to pay $256 million for 23andMe in bankruptcy sale - UPI.com

Timeline cronologica

AMD to sell ZT Systems' manufacturing business to Sanmina in $3 billion deal

Regeneron to Buy 23andMe Out of Bankruptcy for $256 Million

Regeneron to Buy 23andMe Out of Bankruptcy for $256 Million

AMD to sell ZT Systems' manufacturing business to Sanmina in $3 billion deal

Nvidia stock wavers as market turmoil eclipses AI chip announcements

Regeneron Pharmaceuticals to pay $256 million for 23andMe in bankruptcy sale - UPI.com

23andMe Sold To Biotechnology Company For $256 Million